You are here: Industry Insights > Migraine

News List

Mind-Blowing: Amgen's Aimovig Halves Length of Migraine Attacks in Phase III Study .biospace
December 01, 2017
Migraine sufferers may find some new relief as Amgen unveiled results from a late-stage study that shows its Phase III drug Aimovig reduced monthly migraine attacks in half.
Ketamine may help treat migraine pain unresponsive to other therapies europeanpharmaceuticalreview
October 24, 2017
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain…
Cannabinoids suitable for migraine prevention europeanpharmaceuticalreview
June 30, 2017
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
Alder shares slump despite migraine success pharmaphorum
June 29, 2017
Alder BioPharmaceuticals announced that its migraine drug eptinezumab succeeded in a late-stage trial for migraine – but shares immediately fell as investors raised concerns about a strong placebo effect.
EU regulators review Novartis’ migraine drug pharmatimes
June 23, 2017
An experimental therapy being developed by Amgen and Novartis to prevent migraine has been accepted for review in the European Union.
Novartis achieves regulatory milestone for AMG 334 in migraine prevention with EMA filing acceptance cphi-online
June 23, 2017
AMG 334 (erenumab) is the first anti-CGRP monoclonal antibody developed for migraine prevention to receive EMA regulatory filing acceptance.
Panacea inks pact with UNICEF financialexpress
January 20, 2017
Gets US FDA nod for migraine drug

Previous page 1 2 3 4 5 6 7 8 9 Next page